OssDsign Q4: Sales on point, but costs surprised - Redeye

Redeye sees a Q4 with sales coming in according to our estimates, but we note that costs came in higher than expected (both in COGS and OPEX: one-offs related to Cranial and other temporary).

Länk till analysen i sin helhet: https://www.redeye.se/research/974920/ossdsign-q4-sales-on-point-but-costs-surprised?utm_source=finwire&utm_medium=RSS